ANNUAL REPORT

Company

Citius Pharmaceuticals, Inc.

Filed

December 29, 2023

Period of Report

September 30, 2023

Accession Number

0001213900-23-099889

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →